Physician profile
William P Coyle
NPI 1841271046
$1,300.57
in general payments reported to CMS, 2019-2025
18 companies · $24.21 in 2025
The $24.21 reported for 2025 was less than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $190 · 2020: $58.35 · 2021: $322 · 2022: $52.61 · 2023: $297 · 2024: $356 · 2025: $24.21.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $677.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $677.32 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $547.31 | 2021-2024 | Qulipta, Ubrelvy, Vraylar |
| Pfizer INC. | $184.42 | 2019-2025 | |
| Novo Nordisk INC | $128.57 | 2020-2024 | Wegovy |
| Abbott Laboratories | $68.39 | 2021-2024 | Freestyle Libre 3, Freestyle Libre 2 |
| Lilly USA, LLC | $48.40 | 2021 | |
| Astrazeneca Pharmaceuticals LP | $33.67 | 2019-2021 | |
| Edwards Lifesciences Corporation | $33.28 | 2023 | |
| Biohaven Pharmaceuticals, INC. | $31.41 | 2021 | |
| Ethicon US, LLC | $30.14 | 2019 | |
| Dexcom, INC. | $29.76 | 2021 | |
| Glaxosmithkline, LLC. | $26.40 | 2019 | |
| Allergan, INC. | $25.83 | 2019 | |
| Teva Pharmaceuticals USA, INC. | $23.50 | 2019 | |
| Amarin Pharma, INC. | $21.23 | 2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $19.63 | 2021 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $18.83 | 2024 | Veozah |
| Amgen INC. | $18.27 | 2021 | |
| Sanofi-Aventis U.S. LLC | $11.53 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Coyle listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.